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Field application of a monoclonal antibody panel to differentiate 
porcine reproductive and respiratory syndrome virus (PRRSV) 
isolates 
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Department of Veterinary Science 
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Porcine reproductive and respiratory 
syndrome (PRRS) .is recognized as the most 
economically devastating disease of swine 
throughout the world. Nucleotide s!lquencing 
and serological studies have demonstrated 
substantial antigenic variation among 
PRRS virus (PRRSV) isolates (Murtaugh, et al., 
1995; Nelson, et al., 1993, 1996). Recently, 
European-like PRRSV isolates have been 
identified in the US (Rossow, et al. 2000) and 
other new, highly virulent PRRSV isolates have 
appeared and affect sows at all stages of 
gestation causing mortality of adult pigs as well 
as young pigs (Epperson et al., 1997). 
Therefore, it is even more important to control 
the spread of these new strains. Clinical signs 
vary between herds, indic;ating that viruses may 
differ in pathogenicity. Furthermore, effective 
use of vaccines and management approaches to 
control PRRS has not always been successful. 
Pigs previously infected with one strain of 
PRRSV or vaccinated with available modified-
live vaccines may not necessarily be completely 
protected against challenge by all other isolates 
or strains of PRRSV. Therefore, producers are 
concerned about introducing new, possibly more 
virulent forms of the virus into already infected 
herds. Producers are also using various 
acclimation protocols to introduce new 
replacement animals to PRRSV strains present 
in a herd to avoid · major outbreaks during 
gestation and farrowing. Pork producers have 
an expressed interest in knowing which strains 
of PRRSV are circulating in their herds. This 
information is then used to assist in decisions 
regarding acclimation and ,production and use of 
autogenous vaccines. Currently, the primary 
means of strain differentiation involves 
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nucleotide sequencing of selected regions of the 
PRRSV genome following isolation of the virus. 
There is little understanding of how 
observed sequence differences between 
isolates actually translate to significant antigenic 
differences that influence how the virus affects 
an animal. Antigenic epitopes recognized by 
monoclonal antibodies (MAbs) represent 
st~uctural differences in the viruses rather than 
just nucleotide substitutions that may have no 
effect on virus structure or recognition by the 
host immune system. 
The objectives of this study were 1) To 
develop a marker system based on epitopic 
differences .among PRRSV isolates that will 
allow for the rapid differentiation of PRRSV 
isolates, and 2) To evaluate the application of 
this marker system in large swine production 
systems. · 
(Key Words: PRRSV, antigenic variation, 
monoclonal antibodies) 
Experimental Procedures 
Collaborative studies at _Iowa State 
University and South Dakota State University 
have resulted in a large panel of 60 MAbs 
representing the products of PRRSV open 
reading frames (ORFs) 2 through 7 (Nelson, 
et al., 1996, Yang, et al., 1999). This panel of 
MAbs was used in. an indirect fluorescent 
antibody (IFA) assay ta categorize PRRSV 
isolates into distinct groups (Yang, et al. 1999). 
Ta date, aver 400 American field isolates, the 
European Lelystad virus and four modified-live 
vaccine strains have been evaluated. Seventy 
distinct reactivity patterns were identified among 
these virus isolates (Janes, et al. 1999). This 
assay can clearly differentiate European-like 
isolates from North American isolates and can 
differentiate two of the previously available 
modified-live vaccine strains from field isolates, 
as well as identify many antigenic differences 
among other field isolates (Table 1 ). We then 
evaluated the field application of this MAb panel 
in an effort to categorize PRRSV isolates by 
antigenic variability. To do this, we conducted a 
field survey of 259 PRRSV isolates, followed by 
a survey of additional 136 isolates from two 
large swine production systems. 
Results 
The 259 virus isolates in the initial field 
survey were categorized into 65 distinct groups 
based on differences in MAb reactivity patterns. 
Five additional groups, not previously detected, 
were identified in one of the production systems 
(Table 2). A total of 18 different MAb reactivity 
patterns were identified among the 93 isolates 
from Production System #1. Six different 
patterns were identified among the 42 isolates 
from System #2. The distribution of MAb 
reactivity patterns among isolates from System 
#1 was similar to that of the initial field survey. 
However, the distribution of patterns among 
isolates from System #2 was very different. 
Approximately 79% of the isolates from 
System #2 were unique to that production 
system and were not identified in the field survey 
or System #1 (Table 2). 
PRRSV isolates were obtained from 31 
different sites within Production System #1. 
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TABLE 1. DIFFERENTIATION OF SELECTED MODIFIED-LIVE VACCINES AND 
EUROPEAN PRRSV ISOLATES FROM AMERICAN FIELD ISOLATES USING_ FOUR 
MAbs TO THE NUCLEOCAPSID PROTEIN. 
Monoclonal Antibody 
JsolateNaccine SR30 SDOW17 MR40 JP24 
US Field Isolates + + + + 
lngelvac PRRS® MLV + + + + 
Prime Pac® PRRS + + + 
Suvaxyn® PRRS + + + 
European isolates + + 
TABLE 2. DISTINCT MAb REACTIVITY PATTERNS OBSERVED IN A FIELD 
SURVEY AND IN TWO SEPARATE U.S. SWINE PRODUCTION SYSTEMS. 
*Group 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22-64 
65-69 
70 (Lelystad) 
Total 
Field Survey 
66 (25.6%) 
60 (23.3%) 
22 ( 8.5%) 
12 ( 4.6%) 
7 ( 2.7%) 
6 ( 2.3%) 
5 ( 1.9%) 
5 ( 1.9%) 
5 ( 1.9%) 
3(1.2%) 
3 ( 1.2%) 
3 ( 1.2%) 
2 ( 0.8%) 
2 ( 0.8%) 
2 ( 0.8%) 
2 ( 0.8%) 
2 ( 0.8%) 
2 ( 0.8%) 
2 ( 0.8%) 
2 ( 0.8%) 
2 ( 0.8%) 
42 (16.2%) 
0 ( 0.0%) 
. 0 ( 0.0%) 
259 
Number of Isolates 
System.#1 
30 (32.3%) 
19 (20.4%) 
6 ( 6.5%) 
6 ( 6.5%) 
3 ( 3.2%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
2 ( 2.2%) 
1 ( 1.1%) 
0 ( 0.0%) 
0 ( 0.0%) 
1 ( 1.1%) 
0 ( 0.0%) 
0 ( 0.0%) 
11 (11.8%) 
0 ( 0.0%) 
0 ( 0.0%) 
1 ( 1.1%) 
1( 1.1%) 
0 ( 0.0%) 
12 (12.9%) 
0 ( 0.0%) 
0 ( 0.0%) 
93 
System #2 
9 (20.9%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0:0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%) 
0 ( 0.0%). 
0 ( 0.0%) 
0 ( 0.0%) 
34 (79.1%) 
0 ( 0.0%) 
43 
*MAb reactivity groups 1-64 were originally defined by Yang, et al., 3'0 International Symposium on 
PRRSV, Ploufragan; France. Groups are numbered in descending order based on the number of 
isolates showing a specific reactivity pattern in the initial field survey. Groups 65-69 were only identified 
in Production System #2. Group 70 represents the European Lelystad isolate. 
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